Patient#	Sample#	CASK:(CASK, protein),	CAV2:(CAV2, protein),	CSF2:(CSF2, protein),	EPB41:(EPB41, protein),	EPHB2:(EPHB2, protein),	EZR:(EZR, protein),	Fibronectin:(Fibronectin, protein),	HRAS:(HRAS, protein),	IL8:(IL8, protein),	KNG1:(KNG1, protein),	LAMA1:(LAMA1, protein),	Laminin alpha3:(Laminin alpha3, protein),	MMP2:(MMP2, protein),	NF1:(NF1, protein),	PKC:(PKC, protein),	PKC delta:(PKC delta, protein),	RASA1:(RASA1, protein),	RHOA:(RHOA, protein),	SDCBP:(SDCBP, protein),	TGFB1:(TGFB1, protein),	TNFRSF13B:(TNFRSF13B, protein),	TRAPPC4:(TRAPPC4, protein),	CASP3:(CASP3, protein),	ERK1-2:(ERK1-2, protein),	GNB2L1:(GNB2L1, protein),	SDC2:(PKC, active),(SDC2, protein),	FGFR/FGF/Syndecan-2:(FGFR/FGF, active),(SDC2, active),	MAPK8:(MAPK8, protein),(SDC2, active),	Syndecan-2 dimer:(EPHB2, active),(SDC2, active),	Syndecan-2/Caveolin-2/Ras:(CAV2, active),(HRAS, active),(SDC2, active),(Transformation, active),	Syndecan-2/Ezrin:(EZR, active),(RHOA, active),(SDC2, active),	Syndecan-2/Fibronectin:(Fibronectin, active),(SDC2, active),	Syndecan-2/GM-CSF:(CSF2, active),(Osteoblast, active),(SDC2, active),	Syndecan-2/Kininogen:(KNG1, active),(SDC2, active),	Syndecan-2/Laminin alpha3:(Fibroblast, active),(Laminin alpha3, active),(SDC2, active),	Syndecan-2/MMP2:(MMP2, active),(SDC2, active),	Syndecan-2/IL8:(IL8, active),(SDC2, active),	Syndecan-2/Neurofibromin:(NF1, active),(SDC2, active),	Syndecan-2/RACK1:(GNB2L1, active),(RASA1, active),(SDC2, active),	Syndecan-2/Synbindin:(SDC2, active),(TRAPPC4, active),	Syndecan-2/Syntenin/PI-4-5-P2:(PI-4-5-P2, active),(SDC2, active),(SDCBP, active),	Syndecan-2/TACI:(SDC2, active),(TNFRSF13B, active),	Syndecan-2/TGFB1:(SDC2, active),(TGFB1, active),	Syndecan-2/alpha2/beta1 Integrin:(Fibroblast, active),(LAMA1, active),(Laminin alpha3, active),(SDC2, active),(alpha2/beta1 Integrin, active),	determination of left/right symmetry:(SDC2, active),	positive regulation of stress fiber formation:(SDC2, active),(alpha5/beta1 Integrin, active),	ERK1-2-active:(ERK1-2, active),(ERK1-2-active, protein),(Syndecan-2/GM-CSF, active),	Metastasis:(Syndecan-2/MMP2, active),	PRKACA:(PRKACA, protein),(Syndecan-2/Neurofibromin, active),	Syndecan-2/CASK:(CASK, active),(SDC2, active),	Syndecan-2/PKC delta:(Osteosarcoma, active),(PKC delta, active),(SDC2, active),	actin cytoskeleton reorganization:(Syndecan-2/Fibronectin, active),	angiogenesis:(Syndecan-2/IL8, active),	calcineurin-NFAT signaling pathway:(Syndecan-2/TACI, active),	dendrite morphogenesis:(Syndecan-2 dimer, active),	positive regulation of cell-cell adhesion:(Syndecan-2/Syntenin/PI-4-5-P2, active),	Caspase 3 (tetramer):(CASP3, active),(Syndecan-2/PKC delta, active),	Syndecan-2/CASK/Protein 4.1:(EPB41, active),(Syndecan-2/CASK, active),	extracellular matrix organization:(Syndecan-2/TGFB1, active),	BAX:(BAX, protein),	release of cytochrome c from mitochondria:(BAX, active),(Caspase 3 (tetramer), active),	SRC	Syndecan-2/RasGAP	Syndecan-2/RasGAP/Src:(SRC, active),(Syndecan-2/RasGAP, active),	
